title: Efficacy of once daily nitrendipine in essential hypertension--a study using ambulatory blood pressure monitoring.
abstract: To determine if the calcium channel blocking agent, nitrendipine, is effective as monotherapy we have performed a double-blind placebo-controlled crossover trial using 20 mg once daily or twice daily in 19 mild to moderate hypertensive patients. Blood pressure was measured by a random zero (RZ) sphygmomanometer and at home using the Remler semiautomatic BP recorder. The BP (RZ) was significantly reduced by twice daily nitrendipine compared to placebo (from 163/99 +/- 20/6 mmHg to 140/90 +/- 15/9 mmHg). Once daily drug administration reduced systolic BP only (163 +/- 20 to 144 +/- 17 mmHg). Remler BP confirmed that the maximum systolic and diastolic BP lowering effect was in the twice daily group while once daily drug did produce a significant lowering of BP but less than the twice daily dosage. This study suggests that twice daily nitrendipine caused a greater decrease in BP and was more consistent than once a day. The emergence of a new generation of automatic BP recorders should improve the evaluation of once daily therapeutic agents.
authors.affiliation: Department of Medicine, University of Wales College of Medicine, Llandough Hospital, UK.
authors.forename: J H
authors.initials: JH
authors.lastname: Lazarus
authors.forename: M D
authors.initials: MD
authors.lastname: Littley
authors.forename: D I
authors.initials: DI
authors.lastname: Phillips
mesh_terms: D000328:Adult; D000368:Aged; D001795:Blood Pressure Determination; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009568:Nitrendipine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D009568:Nitrendipine